نتائج البحث

Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a review.

• Authors : Terkola R; Institute of Science in Healthy Ageing & HealthcarE (SHARE, University Medical Center Groningen (UMCG, University of Groningen, The Netherlands.; Department of Pharmacotherapy and Translational Research, University of Florida - College of Pharmacy, Gainesville, USA.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Clinical Coding/Clinical Coding/Clinical Coding/*standards ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

• Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Oct; Vol. 46 (5), pp. 1238-1244. Date of Electronic Publication: 2021 Mar 09.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

تفاصيل العنوان

Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review.

• Authors : Burnett H; Evidera, Montreal, QC, Canada.; Emich H

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Mutagenesis, Insertional*; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*genetics

• Source: PloS one [PLoS One] 2021 Mar 08; Vol. 16 (3), pp. e0247620. Date of Electronic Publication: 2021 Mar 08 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.

• Authors : Cuneo A; Mato AR ...

Subjects: Adenine/Adenine/Adenine/*analogs & derivatives ; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use

• Source: Cancer medicine [Cancer Med] 2020 Nov; Vol. 9 (22), pp. 8468-8479. Date of Electronic Publication: 2020 Sep 24.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.

• Authors : Innominato PF; North Wales Cancer Centre, Betsi Cadwaladr University Health Board, Bangor, United Kingdom.; Division of Biomedical Sciences, Cancer Chronotherapy Team, Cancer Research Centre, Warwick Medical School, Coventry, United Kingdom.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*epidemiology

• Source: Cancer medicine [Cancer Med] 2020 Jun; Vol. 9 (12), pp. 4148-4159. Date of Electronic Publication: 2020 Apr 22.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town?

• Authors : Milunović V; Division of Hematology, Clinical Hospital Merkur, Zagreb, Croatia.; Mišura Jakobac K

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Brentuximab Vedotin/Brentuximab Vedotin/Brentuximab Vedotin/*therapeutic use

• Source: European journal of haematology [Eur J Haematol] 2019 Sep; Vol. 103 (3), pp. 145-151. Date of Electronic Publication: 2019 Jun 17.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

• Authors : Saraceni F; Department of Internal Medicine and Hematology, AV3, ASUR Marche, Macerata, Italy. .; Acute Leukemia Working Party - European Society for Blood and Marrow Transplantation, Paris, France. .

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Busulfan/Busulfan/Busulfan/*analogs & derivatives ; Busulfan/Busulfan/Busulfan/*therapeutic use

• Source: Journal of hematology & oncology [J Hematol Oncol] 2019 Apr 25; Vol. 12 (1), pp. 44. Date of Electronic Publication: 2019 Apr 25.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.

• Authors : Taieb J; Department of Gastroenterology and Digestive Oncology, Université de Paris, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France. .; Université Paris-Cité, Hôpital Européen Georges Pompidou, Hepatogastroenterology and GI Oncology, Paris, France. .

Subjects: Adenocarcinoma* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy; Humans

• Source: BMC cancer [BMC Cancer] 2023 Sep 18; Vol. 23 (1), pp. 877. Date of Electronic Publication: 2023 Sep 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Nintedanib‐αVβ3 Integrin Ligand Dual‐Targeting Conjugates towards Precision Treatment of Melanoma.

• Authors : Bugatti, Kelly¹ (AUTHOR); Sartori, Andrea¹ (AUTHOR); Battistini, Lucia¹ (AUTHOR)

• Source: European Journal of Organic Chemistry. 12/6/2022, Vol. 2022 Issue 45, p1-10. 10p.

تفاصيل العنوان

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma.

• Authors : Lopez-Muñoz N; Hematology Department, Hospital 12 de Octubre, CNIO, Complutense University, Madrid, Spain.; Hernández-Ibarburu G

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis; Humans

• Source: Journal of hematology & oncology [J Hematol Oncol] 2023 Jul 19; Vol. 16 (1), pp. 76. Date of Electronic Publication: 2023 Jul 19.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.

• Authors : de Mello RA; Department of Medical Oncology, Head and Neck Unit, Portuguese Oncology Institute, Porto, Portugal ; Department of Medicine and Biomedical Sciences, School of Medicine, University of Algarve, Faro, Portugal

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

• Source: PloS one [PLoS One] 2014 Feb 06; Vol. 9 (2), pp. e86697. Date of Electronic Publication: 2014 Feb 06 (Print Publication: 2014).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان